Best Performing Stocks To Invest In Right Now

Best Performing Stocks To Invest In Right Now: Oncothyreon Inc .(ONTY)

Oncothyreon Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for the treatment of cancer. Its primary product candidate, Stimuvax is in two phase III clinical trials for the treatment of non-small cell lung cancer. The company is also developing PX-866, a small molecule that is in phase II trials for various cancer indications. In addition, it engages in the preclinical development of ONT-10, a cancer vaccine; and ONT-701, a pan-inhibitor of the B-cell lymphoma-2 family of anti-apoptotic proteins. The company operates primarily in the United States and Canada. Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  D Dipasupil/FilmMagicJustin Bieber's Someday perfume. Plenty of stocks go up and down in any given week. The gainers inspire us to keep investing. The decliners keep greed in check while reminding us about the risks of the equity markets. Let's go over some of last week's best and worst performers. China Finance Online (JRJC) -- Up 131 percent last week The market's biggest winner last week was China Finance Online, more than doubling after introducing a new trading platform. The Beijing-based financial website operator announced that the new offering was the country's first integrated, Web-based securities trading service platform. At least one noted worrywart disputed the claim. Citron Research -- a popular publisher of bearish reports on stocks -- tweeted that sloppy reporting and a misleading headline were making it seem as if no other online trading platform existed in the world's most populous nation. The bulls won out. Shares of China Finance Online closed sharply higher in each of last week's five trading days. TrueCar (TRUE) -- Up 33 percent last week Closer to home, another online platform moved nicely higher after striking a deal with! Chrysler and auto insurer GEICO (BRK-A). TrueCar operates a negotiation-free car buying and selling platform. It launched a platform that could shake up the insurance industry, where roughly 3 million cars are totaled each year. Insurers have typically just written a settlement check and provided a rental car voucher to cover the incident, but TrueCar's new plan would work with launch partners GEICO and Chrysler -- and other members of its insurance affinity partners in the future -- to work with the insured to directly replace the vehicle. TrueCar went public at $9 just three months ago. The stock has been revving higher, going on to more than double in its brief time on the market. American Eagle Outfitters (AEO) -- Up 26 percent last week Shares of American Eagle Outfitters moved higher after it posted b

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Wednesday’s session are Mako Surgical Corp.(MAKO), Ascena Retail Group Inc.(ASNA) and Oncothyreon Inc.(ONTY)

• [By James E. Brumley]

  On paper, Oncothyreon Inc. (NASDAQ:ONTY) doesn't look like a particularly compelling investment. The pre-revenue biotech company is poised to keep booking sizable losses as it continues to work on its lung cancer drug tecemotide (formerly Stimuvax), which has rejected by the FDA last year but is still being reworked for a slightly different illness than was being targeted initially. And, with no other Phase 3 drug in its pipeline, traders may be rightfully wondering if there's any real catalyst for ONTY in the foreseeable future.

• [By Roberto Pedone]

  One under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Oncothyreon (ONTY), which develops and markets synthetic vaccines and small molecules that treat cancer patients. This stock hasn't done much so far in 2013, with shares down modestly by 3.9%.

  If you take a look at the chart for Oncothyreon, you'! ll notice! that this stock has been trending sideways inside of a consolidation chart pattern for the last month and change, with shares moving between $1.63 on the downside and $1.95 on the upside. Shares of ONTY have been finding some buying interest of late right above its 50-day moving average of $1.73 a share. This stock is now starting to push within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.

  Traders should now look for long-biased trades in ONTY if it manages to break out above some near-term overhead resistance levels at $1.93 to $1.95 a share and then once it takes out more resistance at $1.98 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 689,364 shares. If that breakout triggers soon, then ONTY will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $2.12 a share to $2.70 a share.

  Traders can look to buy ONTY off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $1.73 a share or around more support at $1.63 a share. One can also buy ONTY off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/best-performing-stocks-to-invest-in-right-now-3.html